Pages that link to "Q43698929"

The following pages link to Impact of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia (Q43698929):

Displaying 22 items.

• DNA Methylation and Chromatin Remodeling: The Blueprint of Cancer Epigenetics (Q26749421) (← links)
• Histone acetylation: novel target for the treatment of acute lymphoblastic leukemia (Q26778780) (← links)
• Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio. (Q33939797) (← links)
• Leukaemogenesis: more than mutant genes (Q34275371) (← links)
• Evidence for involvement of medium chain acyl-CoA dehydrogenase in the metabolism of phenylbutyrate (Q34310919) (← links)
• New drugs in acute myeloid leukemia (Q34774151) (← links)
• Myelodysplastic syndrome and histone deacetylase inhibitors: "to be or not to be acetylated"? (Q35001132) (← links)
• Cancer epigenetics: linking basic biology to clinical medicine. (Q35348043) (← links)
• Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias (Q35750919) (← links)
• Epigenetics as a therapeutic target in breast cancer (Q36449057) (← links)
• Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias (Q37184917) (← links)
• Future directions in myelodysplastic syndrome: newer agents and the role of combination approaches (Q37277999) (← links)
• Targeting histone deacetylases for the treatment of disease (Q37296159) (← links)
• Epigenetic therapy of leukemia: An update (Q37307226) (← links)
• Histone Modification Therapy of Cancer (Q37797706) (← links)
• Epigenetic modifications as therapeutic targets (Q37800011) (← links)
• Role of epigenetic therapy in myelodysplastic syndrome (Q37810062) (← links)
• A focus on the preclinical development and clinical status of the histone deacetylase inhibitor, romidepsin (depsipeptide, Istodax(®)). (Q39248784) (← links)
• N-myc Downstream-regulated Gene 1 (NDRG1) a Differentiation Marker of Human Breast Cancer (Q39609451) (← links)
• Phenylbutyrate induces antimicrobial peptide expression (Q39796789) (← links)
• Identification of enzymes involved in oxidation of phenylbutyrate (Q42290254) (← links)
• Synergistic Killing Effect between Vorinostat and Target of CD146 in Malignant Cells (Q42872567) (← links)